Lupus-like membranous nephropathy. Is it lupus? Report of 5 cases in a reference hospital in Mexico
Article
-
- Overview
-
- Research
-
- Identity
-
- Additional Document Info
-
- View All
-
Overview
abstract
-
Introduction: Lupus nephritis requires antinuclear antibodies as classification criteria. There is a group of patients with nephrotic syndrome and conclusive histopathological findings for lupus nephritis, without classification criteria for systemic lupus erythematosus (SLE) or extrarenal manifestations. These groups of patients have been described as “lupus-like” nephritis or “renal-limited lupus nephritis”. Methods: Renal biopsy with histopathological evaluation with “full-house” immune-reactants in patients with negative antinuclear antibodies. Results: We report four cases with nephrotic syndrome and one with hematuria-proteinuria syndrome: two with impaired glomerular filtration rate and three with preserved renal function; urinary sediment with hematuria without dysmorphia and without extrarenal manifestations for autoimmune disease, negative antinuclear antibodies (ANA) and anti-double stranded DNA (anti-dsDNA); normal C3 and C4 complement levels. Renal biopsy in all cases was consistent for lupus nephritis class V. All patients received treatment as lupus nephritis protocol; only one case received induction with cyclophosphamide and methylprednisolone boluses, the rest received mycophenolic acid and prednisone as induction and maintenance. Two of the cases induced with mycophenolic acid relapsed, requiring cyclophosphamide for 6 months, achieving complete remission. All patients received renin-angiotensin-aldosterone system blockade and hydroxychloroquine. At follow-up, 4 cases still have negative antibodies and are without extrarenal manifestations for SLE classification criteria. The other case, during pregnancy several years after initial diagnosis, had preeclampsia with nephrotic proteinuria and a new determination of positive ANA and anti-dsDNA antibodies, complement levels below normal limits. Conclusion: The follow-up of patients with membranous glomerulopathy must be close; lupus like nephritis may be the first manifestation of the disease. © The Author(s) 2021.
publication date
published in
Research
keywords
-
antinuclear antibodies; full house pattern; membranous nephropathy; renal-limited lupus nephritis; systemic lupus erythematosus; “Lupus-like” nephritis antinuclear antibody; azathioprine; calcineurin inhibitor; calcitriol; calcium antagonist; cholesterol; complement component C1q; complement component C3; complement component C4; creatinine; cyclophosphamide; double stranded DNA antibody; fibrinogen; furosemide; glucose; hydroxychloroquine; immunoglobulin A; immunoglobulin G; immunoglobulin M; levothyroxine; low density lipoprotein cholesterol; methylprednisolone; mycophenolic acid; nifedipine; phospholipase A2 receptor; prazosin; prednisone; rituximab; rosuvastatin; serum albumin; tacrolimus; thyrotropin; triacylglycerol; anti-dsDNA autoantibody; antinuclear antibody; complement; cyclophosphamide; mycophenolic acid; adult; aged; albumin to creatinine ratio; albuminuria; ambient air; anasarca; antigen antibody complex; arteriosclerosis; arthritis; Article; autoimmune disease; basement membrane; behavior; blood cell count; body height; body weight; capillary wall; clinical article; clinical evaluation; clinical feature; collagen disease; colonoscopy; consultation; controlled study; creatinine blood level; drug dose reduction; drug substitution; drug withdrawal; dyslipidemia; dyspnea; emergency ward; female; follow up; free thyroxine index; glomerulus filtration rate; heart rate; hematuria; hematuria proteinuria syndrome; histopathology; hospital admission; hospitalization; human; human tissue; humoral immune deficiency; hypertension; hypothyroidism; immune complex deposition; immunofluorescence; inflammatory infiltrate; interstitium; kidney biopsy; kidney dysfunction; kidney fibrosis; kidney function; kidney hypertrophy; laboratory test; leg edema; lupus erythematosus nephritis; lupus like membranous nephropathy; lupus like syndrome; maintenance therapy; male; medical history; membranous glomerulonephritis; Mexico; middle aged; nephrotic syndrome; non insulin dependent diabetes mellitus; oxygen saturation; patient referral; physical examination; pleura effusion; podocyte; preeclampsia; pregnancy; primigravida; proteinuria; remission; renin angiotensin aldosterone system; sclerosis; seroconversion; single drug dose; synovitis; systemic lupus erythematosus; thorax radiography; thrombocytopenia; ultrasound guided biopsy; urinalysis; urine sediment; urogenital endoscopy; vascular disease; case report; complication; hospital; lupus erythematosus nephritis; membranous glomerulonephritis; proteinuria; systemic lupus erythematosus; Antibodies, Antinuclear; Complement System Proteins; Cyclophosphamide; Female; Glomerulonephritis, Membranous; Hematuria; Hospitals; Humans; Lupus Erythematosus, Systemic; Lupus Nephritis; Mexico; Mycophenolic Acid; Pregnancy; Proteinuria
Identity
Digital Object Identifier (DOI)
PubMed ID
Additional Document Info
start page
end page
volume
issue